Multidisciplinary approach

Tumori

Volumn 96, Issue 5, 2010, Pages 833-836

  De Herder, Wouter W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HUMAN; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PANCREAS TUMOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION;

EID: 78650491073     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600537     Document Type: Conference Paper

References (9)

1. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A: Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol, 9: 61-72, 2008.
2. Solcia E, Klöppel G, Sobin LH: Histological Typing of Endocrine Tumours. World Health Organization International Histological Classification of Tumours. Springer-Verlag, Berlin, 2000.
3. Rindi G, Klöppel G, Alhman H, Caplin M, Coulevard A, de Herder WW, Eriksson B, Falchetti A, Falconi M, Komminoth P, Körner M, Lopes JM, McNicol A-M, Nilsson O, Perren A, Scarpa A, Scoazec J-Y, Wiedenmann B and all other Frascati Consensus Conference participants: TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 449: 395-401, 2006.
4. Rindi G, Klöppel G, Coulevard A, Komminoth P, Körner M, Lopes JM, McNicol A-M, Nilsson O, Perren A, Scarpa A, Scoazec J-Y, Wiedenmann B: TMN staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 451: 757-762, 2007. (Pubitemid 47497934)
5. Pape UF, Jann H, Müller-Nordhorn J, Bockelbrink A, Berndt U, Willich SN, Koch M, Röcken C, Rindi G, Wiedenmann B: Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer, 113: 256-265, 2008.
6. Fisher L, Kleeff J, Esposito I, Hinz U, Zimmermann A, Friess H, Büchler MW: Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surgery, 95: 627-635, 2008.
7. Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, de Jong M, de Herder WW, Krenning EP: Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors. Endocr Relat Cancer, 17: 53-73, 2010.
8. Krausz Y, Keidar Z, Kogan I, Even-Sapir E, Bar-Shalom R, Engel A, Rubinstein R, Sachs J, Bocher M, Agranovicz S, Chisin R, Israel O: SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf ), 59: 565-573, 2003.
9. Buchmann I, Henze M, Engelbrecht S, Eisenhut M, Runz A, Schäfer M, Schilling T, Haufe S, Herrmann T, Haberkorn U: Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging, 34: 1617-1626, 2007. (Pubitemid 47476920)